Researching: Novo Nordisk
Pulling real-time news, deal activity, and upcoming catalysts
Analyzing sources for "Novo Nordisk"...
RxInsider Coverage (10)
The Week
Pharma's new CEOs to watch
Aug 27
The Week
How cost and perception could reshape the GLP-1 market
Aug 21
The Week
How cost and perception could reshape the GLP-1 market
Aug 19
The Week
The Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2
Aug 9
The Week
Lilly and Novo Nordisk score an early antitrust win, but the policy fight isn’t over
Aug 8
The Week
Eli Lilly raises 2026 outlook again as Q2 soars past estimates
Aug 6
The Week
Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 fail
Aug 1
The Week
Sublingual semaglutide offered to UK practices despite Novo Nordisk concerns
Jul 31
The Week
Novo Nordisk’s GLP‑1 suit and Anthropic’s biotech push headline the week
Jul 22
The Week
Agios scraps sickle cell drug
Jul 21
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.